PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsatopic dermatitis
MeSH D003876 - atopic dermatitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D003872:Dermatitis
$
Success rate
D006969:Immediate hypersensitivity
0 Companies
0 Drugs
Success rate
D017443:Eczematous skin diseases
0 Companies
0 Drugs
Success rate
D012873:Genetic skin diseases
$
Success rate
D003876: 
Atopic dermatitis
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyCortisone Cortisone  1982-01-01   
Methylprednisolone Methylprednisolone  1982-01-01   
Prednisolone Prednisolone  1982-01-01   
Prednisone Prednisone  1982-01-01   
Abbott BiotherapeuticsMethylprednisolone A-methapred  1991-02-22   
AbbVieTriamcinolone Azmacort  1982-04-23   
Prednisolone Pred  1982-01-01   
Prednisolone Pred Mild  1982-01-01   
Accord HealthcareTacrolimus Tacrolimus  2011-08-31   
AkornTriamcinolone Triamcinolone  2016-08-11   
Alcon ResearchPrednisolone, Sulfacetamide Cetapred  1993-08-06   
Prednisolone Prednisolone  1991-10-24   
Prednisolone, Sulfacetamide Isopto Cetapred  1982-01-01   
Alembic PharmaceuticalsNystatin, Triamcinolone Nystatin Triamcinolone  2021-03-31   
Alimera SciencesFluocinolone acetonide Iluvien 2027-08-12 2014-09-26   
Fluocinolone acetonide Yutiq 2027-08-12 2018-10-12   
Alkem LaboratoriesTriamcinolone Triamcinolone  2017-12-26   
Tacrolimus Tacrolimus  2020-11-12   
1
2
3
4
5
6
...
15
>
Clinical Trials
Historical Success Rate
Phase 1
65%
31/48
Phase 2
44%
36/81
Phase 3
65%
47/72
Approved: 23Overall Success rate: 19%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
AbbVie
1
2
3
4
5
6
...
10
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use